Chordia Therapeutics (TSE:190A) Inventory Turnover: 0.00 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
12 GF Score
Price 円78.00
! 2 Warning Signs
View Full Analysis

What is Chordia Therapeutics Inventory Turnover?

Chordia Therapeutics TSE:190A 12 Inventory Turnover is 0.00 as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Chordia Therapeutics's Cost of Goods Sold for the six months ended in Feb. 2026 was 円510.33 Mil. Chordia Therapeutics's Average Total Inventories for the quarter that ended in Feb. 2026 was 円0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Chordia Therapeutics's Days Inventory for the six months ended in Feb. 2026 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Chordia Therapeutics  (TSE:190A) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Chordia Therapeutics's Days Inventory for the six months ended in Feb. 2026 is calculated as:

Days Inventory =Average Total Inventories (Q: Feb. 2026 )/Cost of Goods Sold (Q: Feb. 2026 )*Days in Period
=0/510.333*365 / 2
=0.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Chordia Therapeutics's Inventory to Revenue for the quarter that ended in Feb. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Feb. 2026 ) / Revenue (Q: Feb. 2026 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Chordia Therapeutics Inventory Turnover Related Terms


Chordia Therapeutics Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Inventory Turnover Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Inventory Turnover
0.00 0.00 0.00 0.00 0.00

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Inventory Turnover Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
TSE:190A
12GF Score
Chordia Therapeutics Inc TSE:190A
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics Inventory Turnover Calculation

Chordia Therapeutics's Inventory Turnover for the fiscal year that ended in Aug. 2025 is calculated as

Inventory Turnover (A: Aug. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Aug. 2025 ) / ((Total Inventories (A: Aug. 2024 ) + Total Inventories (A: Aug. 2025 )) / count )
=1425.309 / ((0 + 0) / 1 )
=1425.309 / 0
=N/A

Chordia Therapeutics's Inventory Turnover for the quarter that ended in Feb. 2026 is calculated as

Inventory Turnover (Q: Feb. 2026 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Feb. 2026 ) / ((Total Inventories (Q: Aug. 2025 ) + Total Inventories (Q: Feb. 2026 )) / count )
=510.333 / ((0 + 0) / 1 )
=510.333 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 0.00 mean?
Chordia Therapeutics (TSE:190A) has a Inventory Turnover of 0.00 as of Feb. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Chordia Therapeutics and its competitors.
Is Chordia Therapeutics' Inventory Turnover too high?
Chordia Therapeutics' current Inventory Turnover is 0.00. Overall, Chordia Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' Inventory Turnover compare to VRTX and REGN?
Chordia Therapeutics' Inventory Turnover of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Biotechnology company?
A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Chordia Therapeutics and its competitors. Chordia Therapeutics's current Inventory Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current Inventory Turnover of 0.00. The current Inventory Turnover is 0.00. Chordia Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current Inventory Turnover is 0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
12GF Score

Get the complete analysis for TSE:190A

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円78.00
Price